# Haiying Xu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/haiying-xu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,189 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 39 |
| i10-index | 47 |
| Last Known Institution | Bloomberg (United States) |
| OpenAlex ID | https://openalex.org/A5103739466 |
| Works | 62 |

## Researcher papers

- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://scholariq.org/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas](https://scholariq.org/papers/combination-therapy-with-anti-pd-1-anti-tim-3-and-focal-radiation-results-in/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Breast Implant and Reconstruction](https://scholariq.org/topics/breast-implant-and-reconstruction/)

## Researcher university

- [Bloomberg (United States)](https://scholariq.org/institutions/bloomberg-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.